المؤلفون: Courrèges, J-P, Vilsbøll, T, Zdravkovic, M, Le-Thi, T, Krarup, T., Schmitz, O, Verhoeven, R, Bugáñová, I, Madsbad, S

المصدر: Courrèges , J-P , Vilsbøll , T , Zdravkovic , M , Le-Thi , T , Krarup , T , Schmitz , O , Verhoeven , R , Bugáñová , I & Madsbad , S 2008 , ' Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes ' , Diabetic Medicine , vol. 25 , no. 9 , pp. 1129-31 . https://doi.org/10.1111Test/j.1464-5491.2008.02484.x

الإتاحة: https://doi.org/10.1111Test/j.1464-5491.2008.02484.x
https://pure.au.dk/portal/da/publications/beneficial-effects-of-oncedaily-liraglutide-a-human-glucagonlike-peptide1-analogue-on-cardiovascular-risk-biomarkers-in-patients-with-type-2-diabetesTest(6a479270-f9c2-11dd-8f9a-000ea68e967b).html

المؤلفون: Courrèges, J-P, Vilsbøll, Tina, Zdravkovic, M, Le Thi Thanh, Xuan, Krarup, T, Schmitz, Ole, Verhoeven, R, Bugáñová, I, Madsbad, S

المصدر: Courrèges , J-P , Vilsbøll , T , Zdravkovic , M , Le Thi Thanh , X , Krarup , T , Schmitz , O , Verhoeven , R , Bugáñová , I & Madsbad , S 2008 , ' Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes ' , Diabetic Medicine , vol. 25 , no. 9 , pp. 1129-31 . https://doi.org/10.1111Test/j.1464-5491.2008.02484.x

الإتاحة: https://doi.org/10.1111Test/j.1464-5491.2008.02484.x
https://curis.ku.dk/portal/da/publications/beneficial-effects-of-oncedaily-liraglutide-a-human-glucagonlike-peptide1-analogue-on-cardiovascular-risk-biomarkers-in-patients-with-type-2-diabetesTest(5bd91833-ba37-44c9-ae17-f464c1850b58).html